01:48:10Canada

Kamada Ltd. (KMDA)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
180,460,000 12.1%
Net income
20,198,000 39.7%
Gross profit
76,407,000
Operating income
26,233,000
Earnings per share
0.35 40%
R&D expense
12,995,000

Growth and profitability

Gross margin
42.34
Operating margin
14.54
Net margin
11.19
Return on equity
7.51
Return on assets
5.33

Balance sheet

Total assets
378,710,000
Shareholders' equity
269,070,000
Cash and equivalents
75,469,000
Current ratio
4.07

Cash flow and ratios

Operating cash flow
25,490,000
Interest coverage
30.36

Shareholder returns

Dividends paid
11,534,000
Shares outstanding
57,686,056
Book value per share
4.66
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Rehovot, L3
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Kamada Ltd. trades on NASDAQ under the ticker symbol KMDA. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis